scispace - formally typeset
F

Francesco Raimondi

Researcher at University of Naples Federico II

Publications -  204
Citations -  6409

Francesco Raimondi is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Population & GTPase. The author has an hindex of 40, co-authored 186 publications receiving 4898 citations. Previous affiliations of Francesco Raimondi include Yeshiva University & University of Maryland, Baltimore.

Papers
More filters
Journal ArticleDOI

Illuminating G-Protein-Coupling Selectivity of GPCRs.

TL;DR: This work systematically quantified ligand-induced interactions between 148 GPCRs and all 11 unique Gα subunit C termini, and identified sequence-based coupling specificity features, inside and outside the transmembrane domain, which were used to develop a coupling predictor that outperforms previous methods.
Journal ArticleDOI

Wordom: a user-friendly program for the analysis of molecular structures, trajectories, and free energy surfaces.

TL;DR: The following new analysis modules have been added since the publication of the original Wordom paper in 2007: assignment of secondary structure, calculation of solvent accessible surfaces, elastic network model, motion cross correlations, protein structure network, shortest intra‐molecular and inter‐molescular communication paths, kinetic grouping analysis, and calculation of mincut‐based free energy profiles.
Journal ArticleDOI

Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation

TL;DR: It is concluded that selected bile acids modulate intestinal permeability via EGF receptor autophosphorylation, occludin dephosphorylated, and rearrangement at the tight junction level and the effect is mediated by the src family kinases and is abolished by EGF treatment.
Journal ArticleDOI

The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns.

TL;DR: The results suggest a useful role for L. reuteri supplementation in improving feeding tolerance and gut function in formula-fed preterm newborns.
Journal ArticleDOI

Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial.

TL;DR: Thirty-one patients with visceral leishmaniasis (VL) caused by Leishmania infantum received liposomal amphotericin B (AmBisome) in a multi-centre study and were cured without significant adverse events and without relapse during 12-24 months of follow-up.